Exciting updates from the 19th International Conference on Genomics: Metagenomics & Health (ICG19·MH) and the 2nd MOHA Alliance Meeting, held on September 20-21 in Harbin!

Co-hosted by the China Medical Education Association, Harbin Medical University’s Fourth Hospital, and the Million Microbiome of Humans Project (#MMHP), this event brought together experts from 7 countries to explore cutting-edge advancements in metagenomics, disease prediction, and microbiome-based health interventions.


Check out the conference highlights and listen to valuable insights from the experts:

Dr. Stanislav Dusko Ehrlich，University London College, UK

Dr. Songphol Malakorn, Chulalongkorn University, Thailand

Dr. Amanda Dixon-Mclver, IGENZ, New Zealand

Prof. Robert Benamouzig, Avicenne Hospital, France

A big thank you to all the speakers and participants for their valuable contributions, fostering a deeper understanding of disease prevention and the importance of early screening. We hope to have more discussions about innovations in health and genomics in the future!



About BGI Genomics

BGI Genomics, headquartered in Shenzhen, China, is the world's leading integrated solutions provider of precision medicine. Its services cover more than 100 countries and regions, involving more than 2,300 medical institutions and 10,000 employees worldwide. In July 2017, as a subsidiary of BGI Group, BGI Genomics (300676.SZ) officially began trading on the Shenzhen Stock Exchange.